SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Josh C. Pleasure, M.D. who wrote (102)2/6/1997 8:15:00 PM
From: Josh C. Pleasure, M.D.   of 371
 
actually, I was referring to this part, "Kaiser Permente (a large hospital chain) on the west coast has contracted to use CEA-Scan exclusively concerning the diagnosis of colo-rectal cancer. They made this decision based on accuracy and cost efficiency. CEA-Scan will also be featured in a cancer symposium hosted by the Society of Surgical Oncologists in Chicago, March 20-23."

The Lehman news has been released publicly by the company. THe above is not verified anywhere official that I've seen. Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News